Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases

Hiwasa,Takaki; Hiwasa,Takaki; Hiwasa,Takaki; Yoshida,Yoichi; Yoshida,Yoichi; Yoshida,Yoichi; Kubota,Masaaki; Kubota,Masaaki; Kubota,Masaaki; Li,Shu-Yang; Li,Shu-Yang; Li,Shu-Yang; Zhang,Bo-Shi; Zhang,Bo-Shi; Zhang,Bo-Shi; Matsutani,Tomoo; Matsutani,Tomoo; Matsutani,Tomoo; Mine,Seiichiro; Mine,Seiichiro; Mine,Seiichiro; Machida,Toshio; Machida,Toshio; Machida,Toshio; Ito,Masaaki; Ito,Masaaki; Ito,Masaaki; Yajima,Satoshi; Yajima,Satoshi; Yajima,Satoshi; Shirouzu,Mikako; Shirouzu,Mikako; Shirouzu,Mikako; Yokoyama,Shigeyuki; Yokoyama,Shigeyuki; Yokoyama,Shigeyuki; Sata,Mizuki; Sata,Mizuki; Sata,Mizuki; Yamagishi,Kazumasa; Yamagishi,Kazumasa; Yamagishi,Kazumasa; Iso,Hiroyasu; Iso,Hiroyasu; Iso,Hiroyasu; Sawada,Norie; Sawada,Norie; Sawada,Norie; Tsugane,Shoichiro; Tsugane,Shoichiro; Tsugane,Shoichiro; Takemoto,Minoru; Takemoto,Minoru; Takemoto,Minoru; Hayashi,Aiko; Hayashi,Aiko; Hayashi,Aiko; Yokote,Koutaro; Yokote,Koutaro; Yokote,Koutaro; Kobayashi,Yoshio; Kobayashi,Yoshio; Kobayashi,Yoshio; Matsushita,Kazuyuki; Matsushita,Kazuyuki; Matsushita,Kazuyuki; Tatsumi,Koichiro; Tatsumi,Koichiro; Tatsumi,Koichiro; Takizawa,Hirotaka; Takizawa,Hirotaka; Takizawa,Hirotaka; Tomiyoshi,Go; Tomiyoshi,Go; Tomiyoshi,Go; Shimada,Hideaki; Shimada,Hideaki; Shimada,Hideaki; Higuchi,Yoshinori; Higuchi,Yoshinori; Higuchi,Yoshinori

doi:10.3892/mi.2024.169

Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases

Authors:
- Takaki Hiwasa
- Yoichi Yoshida
- Masaaki Kubota
- Shu-Yang Li
- Bo-Shi Zhang
- Tomoo Matsutani
- Seiichiro Mine
- Toshio Machida
- Masaaki Ito
- Satoshi Yajima
- Mikako Shirouzu
- Shigeyuki Yokoyama
- Mizuki Sata
- Kazumasa Yamagishi
- Hiroyasu Iso
- Norie Sawada
- Shoichiro Tsugane
- Minoru Takemoto
- Aiko Hayashi
- Koutaro Yokote
- Yoshio Kobayashi
- Kazuyuki Matsushita
- Koichiro Tatsumi
- Hirotaka Takizawa
- Go Tomiyoshi
- Hideaki Shimada
- Yoshinori Higuchi
View Affiliations

Affiliations: Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan, Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143‑8541, Japan, Laboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa 230‑0045, Japan, RIKEN Structural Biology Laboratory, Yokohama, Kanagawa 230‑0045, Japan, Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba, Tsukuba 305‑8575, Japan, Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan, Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo 104‑0045, Japan, Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan, Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan, Department of Laboratory Medicine & Division of Clinical Genetics, Chiba University Hospital, Chiba 260‑8677, Japan, Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan, Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba 260‑0025, Japan, Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama 340‑0203, Japan, Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143‑8541, Japan
Published online on: June 19, 2024 https://doi.org/10.3892/mi.2024.169
Article Number: 45
Copyright : © Hiwasa et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous antibody biomarkers have been reported for cancer and atherosclerosis‑related diseases. The major complications of atherosclerosis and diabetes mellitus (DM) are acute ischemic stroke (AIS), cardiovascular disease (CVD) and chronic kidney disease (CKD). Cancer development is accompanied by arterial disorders, such as angiogenesis and atherosclerosis, and DM is a risk factor for the development of certain types of cancer. Atherosclerosis‑related diseases and cancers are therefore interrelated and could be detected using a common biomarker. In the present study, the initial screening using the protein array method identified KIAA0513 as an antigen recognized by serum IgG antibodies in patients with atherosclerosis. The amplified luminescent proximity homogeneous assay‑linked immunosorbent assay revealed significantly higher serum antibody levels against recombinant KIAA0513 protein in patients with AIS, transient ischemic attack (TIA), DM, CVD, obstructive sleep apnea syndrome (OSAS), CKD and solid cancers, such as esophageal, gastric, colon, lung and breast cancers, compared with healthy donors. A receiver operating characteristic (ROC) analysis revealed that the highest areas under the ROC curves of anti‑KIAA0513 antibodies were obtained for esophageal cancer, nephrosclerosis‑type CKD and DM. Spearman's correlation analysis revealed that serum anti‑KIAA0513 antibody levels were associated with maximum intima‑media thickness and plaque score, which are indices of atherosclerosis and stenosis. Serum anti‑KIAA0513 antibody markers appear to be useful for diagnosing AIS, TIA, DM, CVD, OSAS, CKD and solid cancers, and may reflect common arterial alterations leading to atherosclerotic and cancerous diseases.